Manlio Monti

847 total citations
46 papers, 462 citations indexed

About

Manlio Monti is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Manlio Monti has authored 46 papers receiving a total of 462 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 17 papers in Oncology and 11 papers in Surgery. Recurrent topics in Manlio Monti's work include Gastric Cancer Management and Outcomes (10 papers), Metastasis and carcinoma case studies (7 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). Manlio Monti is often cited by papers focused on Gastric Cancer Management and Outcomes (10 papers), Metastasis and carcinoma case studies (7 papers) and Gastrointestinal Tumor Research and Treatment (5 papers). Manlio Monti collaborates with scholars based in Italy, United States and Japan. Manlio Monti's co-authors include Giovanni Luca Frassineti, Martina Valgiusti, Anita Mangia, Luca Saragoni, M. Marangolo, Emanuela Scarpi, Paolo Morgagni, Alessandro Passardi, Oriana Nanni and Oronzo Brunetti and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Molecular Sciences and Annals of Oncology.

In The Last Decade

Manlio Monti

44 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Manlio Monti Italy 12 195 172 114 102 89 46 462
Geena X. Wu United States 10 289 1.5× 298 1.7× 82 0.7× 46 0.5× 66 0.7× 13 571
Rodica Maricela Anghel Romania 11 169 0.9× 113 0.7× 98 0.9× 72 0.7× 79 0.9× 74 369
Monika Tripathi United Kingdom 11 115 0.6× 68 0.4× 100 0.9× 78 0.8× 180 2.0× 26 544
Masayuki Ota Japan 12 287 1.5× 133 0.8× 63 0.6× 29 0.3× 242 2.7× 37 493
Noriko Kinukawa Japan 12 57 0.3× 68 0.4× 60 0.5× 27 0.3× 122 1.4× 32 467
Han-Lin Hsu Taiwan 12 87 0.4× 105 0.6× 105 0.9× 85 0.8× 81 0.9× 19 352
Changhua Yu China 11 140 0.7× 122 0.7× 257 2.3× 155 1.5× 118 1.3× 23 493
Wan-Lun Hsu Taiwan 6 181 0.9× 48 0.3× 104 0.9× 78 0.8× 48 0.5× 7 355
Mirando Mršić Croatia 15 139 0.7× 96 0.6× 82 0.7× 16 0.2× 36 0.4× 41 562
Kimiyoshi Yokoi Japan 12 166 0.9× 177 1.0× 59 0.5× 22 0.2× 262 2.9× 52 471

Countries citing papers authored by Manlio Monti

Since Specialization
Citations

This map shows the geographic impact of Manlio Monti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Manlio Monti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Manlio Monti more than expected).

Fields of papers citing papers by Manlio Monti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Manlio Monti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Manlio Monti. The network helps show where Manlio Monti may publish in the future.

Co-authorship network of co-authors of Manlio Monti

This figure shows the co-authorship network connecting the top 25 collaborators of Manlio Monti. A scholar is included among the top collaborators of Manlio Monti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Manlio Monti. Manlio Monti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Petracci, Elisabetta, Alessandro Passardi, Annibale Biggeri, et al.. (2024). Baseline and Longitudinal Neutrophil-to-Lymphocyte Ratio as Prognostic Factor for Metastatic Colorectal Cancer: A Secondary Analysis of the ITACa Randomized Trial. JCO Precision Oncology. 8(8). e2300256–e2300256. 1 indexed citations
2.
3.
Passardi, Alessandro, Alessandro Bittoni, Giorgia Marisi, et al.. (2023). Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab. Therapeutic Advances in Medical Oncology. 15. 2656920–2656920. 10 indexed citations
4.
Monti, Manlio, Andrea Prochowski Iamurri, Luca Esposito, et al.. (2023). Association between Pre-Treatment Biological Indicators and Compliance to Neoadjuvant/Perioperative Chemotherapy in Operable Gastric Cancer. Nutrients. 15(16). 3604–3604. 1 indexed citations
5.
Monti, Manlio, et al.. (2023). Hemophagocytic lymphohistiocytosis in gastric cancer: A rare syndrome for the oncologist. Case report and brief review. Frontiers in Oncology. 13. 1010561–1010561. 2 indexed citations
7.
Morgagni, Paolo, Leonardo Solaini, Luca Saragoni, et al.. (2022). Conversion Surgery in Gastric Cancer Carcinomatosis. Frontiers in Oncology. 12. 852559–852559. 4 indexed citations
8.
Passardi, Alessandro, Ilario Giovanni Rapposelli, Emanuela Scarpi, et al.. (2021). Multimodal Treatment with GEMOX Plus Helical Tomotherapy in Unresectable Locally Advanced Pancreatic Cancer: A Pooled Analysis of Two Phase 2 Studies. Biomolecules. 11(8). 1200–1200. 3 indexed citations
9.
Monti, Manlio, Ilaria Massa, Flavia Foca, et al.. (2020). Retrospective analysis of gastric cancer management in a real-world setting: a single-institution experience. Tumori Journal. 106(2). 165–171. 1 indexed citations
10.
Morgagni, Paolo, Leonardo Solaini, Massimo Framarini, et al.. (2018). Conversion surgery for gastric cancer: A cohort study from a western center. International Journal of Surgery. 53. 360–365. 52 indexed citations
11.
Ulivi, Paola, Emanuela Scarpi, Elisa Chiadini, et al.. (2017). Right- vs. Left-Sided Metastatic Colorectal Cancer: Differences in Tumor Biology and Bevacizumab Efficacy. International Journal of Molecular Sciences. 18(6). 1240–1240. 39 indexed citations
12.
Monti, Manlio, Danila Diano, Angelo Delmonte, et al.. (2017). Bordetella bronchiseptica pneumonia in a patient with lung cancer; a case report of a rare infection. BMC Infectious Diseases. 17(1). 644–644. 10 indexed citations
13.
Monti, Manlio, G. Grimble, Christine Norton, et al.. (2016). P531. Inflammatory bowel disease and fatigue: the effect of physical activity and/or omega-3 supplementation. Journal of Crohn s and Colitis. 10(suppl 1). S370–S371. 2 indexed citations
14.
Marchesi, Emanuela, et al.. (2016). AIFA Determination 809/2015 on Phase I Clinical Trials: a new challenge for Italian Research. Annals of Oncology. 27. iv112–iv112. 1 indexed citations
15.
Mangia, Anita, Emanuela Scarpi, Luca Saragoni, et al.. (2015). The potential predictive role of nuclear NHERF1 expression in advanced gastric cancer patients treated with epirubicin/oxaliplatin/capecitabine first line chemotherapy. Cancer Biology & Therapy. 16(8). 1140–1147. 12 indexed citations
16.
Volpi, Annalisa, Oriana Nanni, Franca De Paola, et al.. (2003). HER-2 Expression and Cell Proliferation: Prognostic Markers in Patients With Node-Negative Breast Cancer. Journal of Clinical Oncology. 21(14). 2708–2712. 37 indexed citations
18.
Monti, Manlio, Giovanni Rosti, Ugo De Giorgi, et al.. (2003). Sexual functions after high-dose chemotherapy in survivors of germ cell tumors. Bone Marrow Transplantation. 32(9). 933–939. 6 indexed citations
19.
Monti, Manlio, et al.. (1990). Clinical efficacy and patient tolerance of topical tretinoin therapy in photo-ageing.. PubMed. 18 Suppl 3(861). 35C–40C. 5 indexed citations
20.
Monti, Manlio. (1973). La sclérose systémique progressive (sclérodermie) associée au cancer pulmonaire. Présentation de quatre nouveaux cas.. Schweizerische medizinische Wochenschrift. 103(29). 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026